Namita Thapar, Whole Time Director, Emcure Pharmaceuticals along with Satish Mehta, MD & CEO, Emcure Pharmaceuticals gives insights on Emcure's IPO Issue opening on July 3 and explains why their profits went down in FY24.
#emcurepharma #pharma #ndtvprofit
For more videos subscribe to our channel: www.youtube.com/@NDTVProfitIndia
Visit NDTV Profit for more news: www.ndtvprofit.com/
Don't enter the stock market unaware. Read all Research Reports here: www.ndtvprofit.com/research-reports
Follow NDTV Profit here
Twitter: twitter.com/NDTVProfitIndia , twitter.com/NDTVProfit
LinkedIn: www.linkedin.com/company/ndtvprofit
Instagram: instagram.com/ndtvprofit/
Facebook: facebook.com/NDTVProfit/
Негізгі бет Emcure Pharmaceuticals IPO: Growth Plans, Existing Profit & More | All You Need To Know
Пікірлер: 7